Opinion
13 小时on MSNOpinion
Oklahoma has a drug price problem. It's time for lawmakers to fix it | Opinion
Pharmacists from across the state are describing how they’re struggling to keep up with the growing need for special compounded medications.
Rare disease research faces complex regulations, small patient populations, and high costs. As traditional incentives wane, new FDA guidance and family-friendly trial design will be essential to ...
KNH stressed that canvassing at any stage of the recruitment process will result in automatic disqualification.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈